This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 September 2024.
All research outputs
#16,934,251
of 26,680,103 outputs
Outputs from Molecular Cancer Therapeutics
#3,173
of 4,169 outputs
Outputs of similar age
#65,797
of 156,685 outputs
Outputs of similar age from Molecular Cancer Therapeutics
#7
of 15 outputs
Altmetric has tracked 26,680,103 research outputs across all sources so far. This one is in the 34th percentile – i.e., 34% of other outputs scored the same or lower than it.
So far Altmetric has tracked 4,169 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.0. This one is in the 22nd percentile – i.e., 22% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 156,685 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 54% of its contemporaries.
We're also able to compare this research output to 15 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 53% of its contemporaries.
